NICE warns industry on cost-effectiveness
February 9, 2010Sales and Marketing BMS, Janssen, NICE, Novartis, hta
NICE has turned down three drugs on cost grounds and has urged the pharma industry to do more to help …
Sandy Royden steps down from Huntsworth
February 9, 2010Medical Communications Huntsworth, appointment, medical communications
Huntsworth Health’s European chief executive Sandy Royden is stepping down at the end of March. Sandy, who is expecting a …
ICON promotes Tom O’Leary
February 9, 2010Research and Development ICON, appointment, research and development
Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …
Working Life: Olivier Leupin
February 9, 2010Business Services, Research and Development Novartis, Working Life, careers, careers voice
How did you find your way into your most current role? After receiving a master’s degree in biology at the …
Huntsworth reorganises European health offering
February 9, 2010Medical Communications Huntsworth
Huntsworth Health has completed a reshuffle of its European operations that sees the company align its operations under three brands. …
Ranbaxy woes revealed in FDA warning letter
February 9, 2010Manufacturing and Production Ranbaxy
Ranbaxy has not taken adequate measures to correct deficiencies at its manufacturing plants, according to a communication from the US …
PharmaIntel appoints Jacqui Batchelor
February 8, 2010Business Services, Sales and Marketing PharmaIntel, appointment, sales and marketing
PharmaIntel, the commercial excellence consultancy founded by Gary Killington in 2008, has appointed two new team members to manage the delivery …
Pfizer launches e-payment scheme for emerging markets
February 8, 2010Sales and Marketing Pfizer, discount, em, emerging markets
Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …
Roche expands Herceptin franchise
February 8, 2010Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer
Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …
Pfizer to personalise brain tumour vaccine
February 8, 2010Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines
Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
Digital Pharma: UCB’s online epilepsy community
February 8, 2010Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information
UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …
Generics firm press for ‘clear and open’ market
February 8, 2010Sales and Marketing generics, industry
Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …
Carbogen Amcis opens large-scale high-potency API plant
February 8, 2010Manufacturing and Production Carbogen Amcis, Dishman, India
Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …
GSK appoints Philippe Fauchet president of GSK Japan
February 8, 2010Sales and Marketing GlaxoSmithKline, appointment, sales and marketing
GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …
Pharma manufacturing news in brief
February 8, 2010Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners
Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …
UK swine flu cases fall
February 5, 2010Sales and Marketing h1n1, swine flu
The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …
GSK looks to rare diseases research
February 5, 2010Research and Development GlaxoSmithKline, Orphan
GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
Cohn & Wolfe appoints Mike Kan
February 5, 2010Medical Communications Cohn & Wolfe, appointment, medical communications
Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …
Recipharm charms Cobra shareholders into selling up
February 5, 2010Manufacturing and Production Cobra, Recipharm, Wasserburger
Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …
Barker praises OLS model
February 5, 2010Research and Development, Sales and Marketing ABPI, Blueprint, OLS
The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
